失眠治疗反应的时间亚型和特征
Yajie Zhang1,2, Zhaowei Jiang1,2, Hongjing Mao3
1The Fourth Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Scientific reports
|July 1, 2025
概括
高等教育,PHQ-9/PHQ-15分数升高和神经病症预测不眠症治疗反应更好. 相反,更长的失眠持续时间与较差的结果和延迟的治疗疗效有关.
科学领域:
- 睡眠医学 睡眠医学
- 精神病学是一个精神病学.
- 行为科学 行为科学
背景情况:
- 失眠是一种普遍存在的睡眠障碍,影响生活质量.
- 预测治疗疗效和发病时间对于个性化患者护理至关重要.
- 失眠的数字认知行为疗法 (CBT-I) 是一种成熟的治疗方式.
研究的目的:
- 确定患者特征,预测治疗疗效和数字CBT-I在失眠中的发病时间.
- 分析基线心理和人口因素与治疗反应之间的关系.
- 区分早期和晚期响应数字CBT-I的响应者.
主要方法:
- 对834名接受数字CBT-I的失眠患者进行了回顾性研究.
- 数据收集包括人口统计,PSQI,GAD-7,PHQ-9,PHQ-15,ESS和EPQ.
- 患者分为早期 (≤8周) 和晚期 (>8周或无反应) 治疗组.
主要成果:
- 高等教育,PHQ-9和PHQ-15分数升高以及神经病症预测了更好的治疗反应和更早的疗效开始.
- 较长的失眠持续时间是治疗反应不佳和延迟疗效的重要风险因素.
- 两组之间在性别,家庭失眠史或ESS得分方面没有发现显著差异.
结论:
- 高等教育,特定的心理标志物 (PHQ-9,PHQ-15,神经病),与有利的数字CBT-I结果有关.
- 失眠的持续时间较长会对治疗的有效性和速度产生负面影响.
- 这些发现可以为优化失眠治疗策略的临床实践提供信息.
相关概念视频
Management of Insomnia
328
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
328
Insomnia
132
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
132
Sedatives and Hypnotics Drugs: Miscellaneous Agents
247
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
247
Sedatives and Hypnotics: Overview
679
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
679
Substance Use Disorders Affecting Sleep
225
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
225
CNS Depressants: Barbiturates and Benzodiazepines
480
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
480


